Functional assays for the development of agonistic antibodies
Watch this webinar to discover qualified bioassays assessing therapeutic antibody mechanisms, case studies about agonistic effects in antibodies initially deemed antagonistic, and explore Fc receptor impacts on antibody response in co-culture assays.
From Yale to healthcare leader: Dr Shika Pappoe’s impact on kidney care
By Dr Shika Pappoe - Advisor at Carna Health
The future of mental health treatment: Zelquistinel’s role
By Drug Target Review
The evolution of AI in drug discovery: learning from history’s mistakes (Part 1)
By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers), Sujeegar…
Navigating the AI revolution: a roadmap for pharma’s future
By Alessio Zoccoli, Carlos N Velez, Remco Jan Geukes Foppen,…
Scientists discover key to long COVID lung damage and potential treatment
Scientists at the University of Virginia (UVA) School of Medicine have uncovered a crucial mechanism behind the lingering effects of long COVID, revealing how severe COVID-19 infections impair immune cells’ ability to repair lung tissue.
First AI-designed drug, Rentosertib, officially named by USAN
Insilico Medicine’s AI-designed drug for idiopathic pulmonary fibrosis (IPF), Rentosertib, has been granted an official name by USAN. This is the first drug where both the target and compound were discovered using generative AI, marking a major milestone in AI-driven drug development.
The evolution of AI in drug discovery: learning from history’s…
By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers), Sujeegar…
Navigating the AI revolution: a roadmap for pharma’s future
By Alessio Zoccoli, Carlos N Velez, Remco Jan Geukes Foppen,…